Shanghai Shen Lian Biomedical Corporation reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 122.16 million compared to CNY 137.85 million a year ago. Revenue was CNY 123.07 million compared to CNY 138.26 million a year ago.

Net income was CNY 9.93 million compared to CNY 23.29 million a year ago. Basic earnings per share from continuing operations was CNY 0.02 compared to CNY 0.06 a year ago. Diluted earnings per share from continuing operations was CNY 0.02 compared to CNY 0.06 a year ago.